BioWorld MedTech

March 20, 2014

View Archived Issues

Washington Roundup: NHLBI eyes TGF-beta as culprit in failure of saphenous vein graft

Court Report: Biolitec CEO a no-show in court, must pay $74.9M to AngioDynamics

HIT Roundup: Health Level introduces software solution for cardiology centers

Financings roundup: Augmedix gets venture funds to expand technology team

Product briefs

People in Places

MDD's Orthopedic Extra

Move could help quell chaotic market: China prepares to crack down on host of device rule breakers

Chinese authorities are taking action to tackle illegal sales and marketing activities in the medical devices as they work to consolidate a market that remains chaotic. Read More

The MDD Interview: Esaote seeks growth by expanding portfolio, markets

Today's news in brief

BioWorld

BioWorld briefs for March 19, 2026.

Precision psychiatry beyond, or before, biomarkers

BioWorld

There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...

Keros reports beneficial effects of RKER-065 in ALS model

BioWorld Science

Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.

News in brief

BioWorld Asia

BioWorld Asia briefs for March 17, 2026

ADPD 2026: Can we prevent dementia? Scientists quantify it

BioWorld

Neurodegenerative disease and cognitive decline cannot be explained by a single process. Beta-amyloid plaques, hyperphosphorylated tau, alpha-synuclein, activated...